|
Jul 25
|
Viking Stock Jumps After Company Speeds Development Its Weight-Loss Pill
|
|
Jul 21
|
How a single daily pill could soon be the future of losing weight
|
|
Jul 20
|
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs?
|
|
Jul 19
|
CrowdStrike outage, Biden, Fifth Third Bank CEO: Catalysts
|
|
Jul 19
|
Eli Lilly Gets Green Light To Sell Weight-Loss Drug in China
|
|
Jul 19
|
Eli Lilly stock soars after Zepbound gets approval in China
|
|
Jul 19
|
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
|
|
Jul 19
|
Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug
|
|
Jul 19
|
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
|
|
Jul 19
|
Rivals Emerge to Ozempic and Zepbound—but With a Lag
|
|
Jul 19
|
Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Buzz Heats Up
|
|
Jul 19
|
Nvidia Recently Completed a 10-for-1 Stock Split: Here Are the 3 Likeliest Candidates to Become Wall Street's Next Stock-Split Stocks
|
|
Jul 18
|
Healthcare stocks at an 'inflection point,' analyst says
|
|
Jul 18
|
Jobless claims, healthcare, small caps: Trading Takeaways
|
|
Jul 18
|
Eli Lilly, Novo Nordisk Shares Fall as Weight-Loss Drug Competition Ramps Up
|
|
Jul 18
|
Are we on the brink of another Nasdaq crash?
|
|
Jul 18
|
Top Stock Movers Now: Domino's Pizza, Eli Lilly, DR Horton, and More
|
|
Jul 18
|
The 5 Most Important Stocks to Watch During Q2 Earnings Season
|
|
Jul 18
|
Novo Nordisk, Lilly Slide on Roche's Obesity Drug Study Data
|
|
Jul 1
|
Eli Lilly inks another radiopharma deal, gaining option to buy startup
|